Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn’t already own, ending a long corporate struggle with its U.S.-based cancer drug partner.
Posts Tagged ‘Genentech’
Employees Sound Off on the Future of Genentech: 100% Roche?
In this week’s news, the future of Genentech crept up as word that Roche, a Swiss drug maker which has owned all or majority parts of Genentech since 1990, was planning on an aggressive bid to take over the company in its entirety – which would account for 44% of Genentech shares it does not ... - Read full post
Which CEOs Have Been Naughty or Nice According to Their Employees?
Yes, that’s right. It’s that time of year where we’re making our list and checking it twice trying to find out which CEO’s rated on Glassdoor.com have been naughty or nice in the eyes of their employees this year.
Genentech’s Art Levinson comes in as the #1 rated CEO (with at least 50 employees) with a ... - Read full post
